🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
14/09/2022 0,6900 USD
14/06/2022 0,6900 USD
14/03/2022 0,6900 USD
14/12/2021 0,6900 USD
14/09/2021 0,6500 USD
14/06/2021 0,6500 USD
12/03/2021 0,6202 USD
14/12/2020 0,6202 USD
14/09/2020 0,5821 USD
12/06/2020 0,5821 USD
13/03/2020 0,5821 USD
13/12/2019 0,5821 USD
13/09/2019 0,5248 USD
14/06/2019 0,5248 USD
14/03/2019 0,5248 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/12/1994 18,25 18,67 18,25 18,43 +0,98% 2,29% 9.754.365
19/12/1994 18,19 18,25 18,01 18,25 +0,00% 1,31% 4.221.763
16/12/1994 18,13 18,31 17,95 18,25 +1,32% 1,97% 10.906.746
15/12/1994 18,07 18,19 17,95 18,01 +0,00% 1,32% 4.452.742
14/12/1994 17,89 18,19 17,89 18,01 +0,00% 1,67% 6.263.686
13/12/1994 17,95 18,13 17,95 18,01 +0,00% 1,00% 5.112.144
12/12/1994 17,77 18,01 17,65 18,01 +1,34% 2,01% 4.406.211
09/12/1994 17,53 17,83 17,47 17,77 +1,36% 2,04% 4.321.114
08/12/1994 17,89 17,95 17,47 17,53 -2,33% 2,67% 4.907.574
07/12/1994 17,71 17,95 17,71 17,95 +0,00% 1,35% 5.743.250
06/12/1994 17,95 18,19 17,83 17,95 +0,00% 1,99% 9.693.162
05/12/1994 18,01 18,07 17,83 17,95 -0,33% 1,32% 4.202.899
02/12/1994 17,65 18,07 17,59 18,01 +1,68% 2,70% 4.597.786
01/12/1994 17,65 18,07 17,65 17,71 -0,34% 2,36% 6.267.459
30/11/1994 17,89 18,07 17,71 17,77 +0,00% 2,00% 8.209.194
29/11/1994 17,59 17,77 17,47 17,77 +0,34% 1,69% 4.414.595
28/11/1994 17,47 17,77 17,47 17,71 +1,36% 1,71% 5.197.242
25/11/1994 17,18 17,53 17,18 17,47 +2,09% 2,08% 2.256.763
23/11/1994 17,12 17,24 17,00 17,12 +0,35% 1,39% 6.050.942
22/11/1994 17,35 17,47 17,00 17,06 -3,38% 2,75% 7.464.066
21/11/1994 17,95 18,07 17,59 17,65 -1,99% 2,66% 5.231.826
18/11/1994 17,59 18,13 17,47 18,01 +2,03% 3,73% 10.178.176
17/11/1994 17,83 18,07 17,47 17,65 +0,00% 3,34% 8.393.432
16/11/1994 17,41 17,65 17,35 17,65 +1,02% 1,71% 3.346.474
15/11/1994 17,71 17,77 17,35 17,47 -1,68% 2,36% 4.974.856
14/11/1994 17,53 17,89 17,47 17,77 +1,36% 2,38% 3.595.898
11/11/1994 17,71 17,77 17,53 17,53 -1,01% 1,35% 4.919.941
10/11/1994 17,65 17,95 17,59 17,71 +1,02% 2,03% 9.053.043
09/11/1994 17,53 17,59 17,41 17,53 +2,80% 1,02% 10.744.515
08/11/1994 16,88 17,24 16,82 17,06 +1,42% 2,47% 4.001.054